Policy Advocacy Against Data Exclusivity

Advocacy Paper I : This explains how the data exclusivity is truly a TRIPS-Plus privilege and why it is not a mandatory measure under the TRIPS Agreement in force.

Advocacy Paper II : This explains how the data exclusivity, if granted , would run counter to the object of India’s Patents act 1970/2005.

Advocacy Paper III : This explains the difference between data protection and data exclusivity. Both are different, as shown in this paper.

Ideally, these must be presented and read successively – one after another.

They present cogent agreement against data exclusivity in India.

Together, they effectively counter the demand for data exclusivity from the other camp.

It also subtly conveys a message that data exclusivity, if granted to pesticides will be laterally extended to pharma too.